GERN Q4 2023 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23,000-77.7% YoY

Gross Profit

$23,000100.0% margin

Operating Income

-$54M-236039.1% margin

Net Income

-$52M-225969.6% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-86.0%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$394M

Total Liabilities

$146M

Stockholders' Equity

$248M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23,000	$103,000	-77.7%
Gross Profit	$23,000	-$27M	+100.1%
Operating Income	-$54M	-$42M	-29.4%
Net Income	-$52M	-$43M	-21.9%